恩昔芬净（Ohtuvayre）用于慢性阻塞性肺疾病。 - Suppr | 超能文献

相似文献

1

Ensifentrine (Ohtuvayre) for COPD.恩昔芬净（Ohtuvayre）用于慢性阻塞性肺疾病。

Med Lett Drugs Ther. 2024 Aug 19;66(1709):131-133. doi: 10.58347/tml.2024.1709b.

2

Drugs for COPD.慢性阻塞性肺疾病用药

Med Lett Drugs Ther. 2024 Sep 2;66(1710):137-144. doi: 10.58347/tml.2024.1710a.

3

A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD.一项评估吸入型双重磷酸二酯酶 3 和 4 抑制剂恩西司特林治疗 COPD 的剂量范围研究。

Respir Res. 2020 Feb 10;21(1):47. doi: 10.1186/s12931-020-1307-4.

4

Ensifentrine (Ohtuvayre™) for chronic obstructive pulmonary disease.恩昔芬净（Ohtuvayre™）用于慢性阻塞性肺疾病。

Trends Pharmacol Sci. 2024 Oct;45(10):941-942. doi: 10.1016/j.tips.2024.08.002. Epub 2024 Sep 10.

5

What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials.依司特伦在慢性阻塞性肺疾病患者治疗中的作用如何？来自近期临床试验的启示。

Immunotherapy. 2023 Dec;15(18):1511-1519. doi: 10.2217/imt-2023-0136. Epub 2023 Oct 2.

6

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review.吸入型双磷酸二酯酶 3/4 抑制剂治疗 COPD 患者：简短综述。

Int J Chron Obstruct Pulmon Dis. 2021 Aug 16;16:2363-2373. doi: 10.2147/COPD.S226688. eCollection 2021.

7

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis.吸入性双磷酸二酯酶3和4抑制剂恩昔芬净治疗中重度慢性阻塞性肺疾病患者后的症状改善——详细分析

Int J Chron Obstruct Pulmon Dis. 2020 Sep 16;15:2199-2206. doi: 10.2147/COPD.S263025. eCollection 2020.

8

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy.一项新型吸入性双重 PDE3 和 4 抑制剂恩西特林在接受噻托溴铵维持治疗的 COPD 患者中的剂量范围研究。

Int J Chron Obstruct Pulmon Dis. 2021 Apr 22;16:1137-1148. doi: 10.2147/COPD.S307160. eCollection 2021.

9

Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD.恩塞福林作为一种新型吸入疗法用于 COPD 患者的治疗。

Int J Chron Obstruct Pulmon Dis. 2023 Jul 28;18:1611-1622. doi: 10.2147/COPD.S413436. eCollection 2023.

10

What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?这些指南中关于慢性阻塞性肺疾病的药物治疗有哪些内容？

Expert Rev Respir Med. 2013 Apr;7(2 Suppl):43-51. doi: 10.1586/ers.13.17.